{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:30:25Z","timestamp":1791959425588,"version":"4.3.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020552","name":"Ministry of Higher Education, Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022107","name":"Universit\u00e9 de Limoges","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.lfs.2024.122792","type":"journal-article","created":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T19:05:38Z","timestamp":1717873538000},"page":"122792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Gut microbiota biotransformation of drug glucuronides leading to gastrointestinal toxicity: Therapeutic potential of bacterial \u03b2-glucuronidase inhibition in mycophenolate-induced enteropathy"],"prefix":"10.1016","volume":"351","author":[{"given":"Clarisse","family":"Brossier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Jardou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Janaszkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djouher","family":"Firoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isy","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Arnion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Pinault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois-Ludovic","family":"Sauvage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Druilhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Di Meo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Marquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2024.122792_bb0005","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/00498254.2013.811314","article-title":"Bacterial \u03b2-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokinetics","volume":"44","author":"Saitta","year":"2014","journal-title":"Xenobiotica"},{"key":"10.1016\/j.lfs.2024.122792_bb0010","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/aps.2016.54","article-title":"Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal \u03b2-glucuronidase activity","volume":"37","author":"Zhong","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.lfs.2024.122792_bb0015","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1021\/acschembio.9b00663","article-title":"Targeting Regorafenib-induced toxicity through inhibition of gut microbial \u03b2-Glucuronidases","volume":"14","author":"Ervin","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.lfs.2024.122792_bb0020","doi-asserted-by":"crossref","first-page":"eaax2358","DOI":"10.1126\/sciadv.aax2358","article-title":"Vancomycin relieves mycophenolate mofetil-induced gastrointestinal toxicity by eliminating gut bacterial \u03b2-glucuronidase activity","volume":"5","author":"Taylor","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.lfs.2024.122792_bb0025","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1517\/14656566.4.12.2325","article-title":"Mycophenolate mofetil in solid-organ transplantation","volume":"4","author":"Srinivas","year":"2003","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.lfs.2024.122792_bb0030","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1016\/S0041-1345(02)03538-8","article-title":"Mechanisms of action of mycophenolate mofetil in preventing chronic rejection","volume":"34","author":"Allison","year":"2002","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.lfs.2024.122792_bb0035","first-page":"91","article-title":"Mycophenolic acid in rheumatology: mechanisms of action and severe adverse events","volume":"62","author":"Zizzo","year":"2010","journal-title":"Reumatismo"},{"key":"10.1016\/j.lfs.2024.122792_bb0040","doi-asserted-by":"crossref","unstructured":"A.I. Al-Absi, C.R. Cooke, B.M. Wall, P. Sylvestre, M.K. Ismail, M. Mya, Patterns of Injury in Mycophenolate Mofetil\u2013Related Colitis, Transplant. Proc. 42 (2010) 3591\u20133593. doi:https:\/\/doi.org\/10.1016\/j.transproceed.2010.08.066.","DOI":"10.1016\/j.transproceed.2010.08.066"},{"key":"10.1016\/j.lfs.2024.122792_bb0045","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2165\/00002018-200124090-00002","article-title":"Adverse gastrointestinal effects of mycophenolate Mofetil","volume":"24","author":"Behrend","year":"2001","journal-title":"Drug-Safety"},{"key":"10.1016\/j.lfs.2024.122792_bb0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.transproceed.2006.10.189","article-title":"Noninfectious gastrointestinal (GI) complications of mycophenolic acid therapy: a consequence of local GI toxicity?","volume":"39","author":"Arns","year":"2007","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.lfs.2024.122792_bb0055","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1124\/dmd.110.034249","article-title":"Involvement of carboxylesterase 1 and 2 in the hydrolysis of mycophenolate mofetil","volume":"38","author":"Fujiyama","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.lfs.2024.122792_bb0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003088-200746010-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients","volume":"46","author":"Staatz","year":"2007","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.lfs.2024.122792_bb0065","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199834060-00002","article-title":"Clinical pharmacokinetics of mycophenolate mofetil","volume":"34","author":"Bullingham","year":"1998","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.lfs.2024.122792_bb0070","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.lfs.2024.122792_bb0075","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13997","article-title":"A short overview on mycophenolic acid pharmacology and pharmacokinetics","volume":"34","author":"Ferreira","year":"2020","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.lfs.2024.122792_bb0080","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2125.2005.02398.x","article-title":"Characterizing the role of enterohepatic recycling in the interactions between mycophenolate mofetil and calcineurin inhibitors in renal transplant patients by pharmacokinetic modelling","volume":"60","author":"Cremers","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.lfs.2024.122792_bb0085","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/ndt\/14.3.706","article-title":"Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: a cross-sectional study","volume":"14","author":"Smak Gregoor","year":"1999","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.lfs.2024.122792_bb0090","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.healun.2018.05.002","article-title":"An intact microbiota is required for the gastrointestinal toxicity of the immunosuppressant mycophenolate mofetil","volume":"37","author":"Flannigan","year":"2018","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.lfs.2024.122792_bb0095","doi-asserted-by":"crossref","unstructured":"J.B. Simpson, J.J. Sekela, A.L. Graboski, V.B. Borlandelli, M.M. Bivins, N.K. Barker, A.A. Sorgen, A.L. Mordant, R.L. Johnson, A.P. Bhatt, A.A. Fodor, L.E. Herring, H. Overkleeft, J.R. Lee, Matthew.R. Redinbo, Metagenomics combined with activity-based proteomics point to gut bacterial enzymes that reactivate mycophenolate, Gut Microbes 14 (2022) 2107289. doi:https:\/\/doi.org\/10.1080\/19490976.2022.2107289.","DOI":"10.1080\/19490976.2022.2107289"},{"key":"10.1016\/j.lfs.2024.122792_bb0100","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s00248-012-0030-1","article-title":"Structural shifts of fecal microbial communities in rats with acute rejection after liver transplantation","volume":"64","author":"Xie","year":"2012","journal-title":"Microb. Ecol."},{"key":"10.1016\/j.lfs.2024.122792_bb0105","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00248-013-0211-6","article-title":"Assessment of microbiome variation during the perioperative period in liver transplant patients: a retrospective analysis","volume":"65","author":"Lu","year":"2013","journal-title":"Microb. Ecol."},{"key":"10.1016\/j.lfs.2024.122792_bb0110","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/ajt.12588","article-title":"Human microbiota characterization in the course of renal transplantation","volume":"14","author":"Fricke","year":"2014","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.lfs.2024.122792_bb0115","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/TP.0000000000000334","article-title":"Intestinal microbial variation may predict early acute rejection after liver transplantation in rats","volume":"98","author":"Ren","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.lfs.2024.122792_bb0120","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/CMR.00063-15","article-title":"The microbiome, systemic immune function, and Allotransplantation","volume":"29","author":"Nellore","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.lfs.2024.122792_bb0125","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/TP.0000000000001492","article-title":"Immunosuppressive treatment alters secretion of Ileal antimicrobial peptides and gut microbiota, and favors subsequent colonization by Uropathogenic Escherichia coli","volume":"101","author":"Tourret","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.lfs.2024.122792_bb0130","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1021\/acscentsci.8b00239","article-title":"Gut microbial \u03b2-Glucuronidase inhibition via catalytic cycle interception","volume":"4","author":"Pellock","year":"2018","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.lfs.2024.122792_bb0135","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1158\/1078-0432.CCR-14-0395","article-title":"Old drug new use\u2014Amoxapine and its metabolites as potent bacterial \u03b2-Glucuronidase inhibitors for alleviating Cancer drug toxicity","volume":"20","author":"Kong","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2024.122792_bb0140","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1177\/1087057112444927","article-title":"Potential repurposing of known drugs as potent bacterial \u03b2-Glucuronidase inhibitors","volume":"17","author":"Ahmad","year":"2012","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.lfs.2024.122792_bb0145","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1126\/science.1191175","article-title":"Alleviating cancer drug toxicity by inhibiting a bacterial enzyme","volume":"330","author":"Wallace","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.lfs.2024.122792_bb0150","doi-asserted-by":"crossref","unstructured":"T. Lea, Caco-2 Cell Line, in: K. Verhoeckx, P. Cotter, I. L\u00f3pez-Exp\u00f3sito, C. Kleiveland, T. Lea, A. Mackie, T. Requena, D. Swiatecka, H. Wichers (Eds.), The Impact of Food Bioactives on Health: In Vitro and Ex Vivo Models, Springer International Publishing, Cham, 2015: pp. 103\u2013111. doi:https:\/\/doi.org\/10.1007\/978-3-319-16104-4_10.","DOI":"10.1007\/978-3-319-16104-4_10"},{"key":"10.1016\/j.lfs.2024.122792_bb0155","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.yexcr.2014.01.021","article-title":"Mycophenolic acid mediated disruption of the intestinal epithelial tight junctions","volume":"322","author":"Qasim","year":"2014","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.lfs.2024.122792_bb0160","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1021\/ct100578z","article-title":"PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions","volume":"7","author":"Olsson","year":"2011","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.lfs.2024.122792_bb0165","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1021\/ct200133y","article-title":"Improved treatment of ligands and coupling effects in empirical calculation and rationalization of pKa values","volume":"7","author":"S\u00f8ndergaard","year":"2011","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.lfs.2024.122792_bb0170","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.lfs.2024.122792_bb0175","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","article-title":"ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution","volume":"16","author":"Tian","year":"2020","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.lfs.2024.122792_bb0180","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1021\/jz501780a","article-title":"Building water models: a different approach","volume":"5","author":"Izadi","year":"2014","journal-title":"J. Phys. Chem. Lett."},{"key":"10.1016\/j.lfs.2024.122792_bb0185","doi-asserted-by":"crossref","first-page":"13279","DOI":"10.1021\/jp902584c","article-title":"Molecular dynamics simulations of the dynamic and energetic properties of alkali and halide ions using water-model-specific ion parameters","volume":"113","author":"Joung","year":"2009","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.lfs.2024.122792_bb0190","doi-asserted-by":"crossref","first-page":"9020","DOI":"10.1021\/jp8001614","article-title":"Determination of alkali and halide monovalent ion parameters for use in explicitly solvated biomolecular simulations","volume":"112","author":"Joung","year":"2008","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.lfs.2024.122792_bb0195","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.lfs.2024.122792_bb0200","doi-asserted-by":"crossref","DOI":"10.1063\/5.0019056","article-title":"A fast and high-quality charge model for the next generation general AMBER force field","volume":"153","author":"He","year":"2020","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.lfs.2024.122792_bb0205","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/jcc.20820","article-title":"GLYCAM06: a generalizable biomolecular force field","volume":"29","author":"Kirschner","year":"2008","journal-title":"Carbohydrates, J Comput Chem"},{"key":"10.1016\/j.lfs.2024.122792_bb0210","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","article-title":"Automatic atom type and bond type perception in molecular mechanical calculations","volume":"25","author":"Wang","year":"2006","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.lfs.2024.122792_bb0215","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u00b7log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.lfs.2024.122792_bb0220","series-title":"AMBER2020","author":"Case","year":"2020"},{"key":"10.1016\/j.lfs.2024.122792_bb0225","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.lfs.2024.122792_bb0230","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1109\/MCSE.2007.55","article-title":"Matplotlib: a 2D graphics environment","volume":"9","author":"Hunter","year":"2007","journal-title":"Computing in Science & Engineering"},{"issue":"33\u201338","key":"10.1016\/j.lfs.2024.122792_bb0235","first-page":"27","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.lfs.2024.122792_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130038","article-title":"Persistence of pathogenic and non-pathogenic Escherichia coli strains in various tropical agricultural soils of India","volume":"10","author":"Naganandhini","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.lfs.2024.122792_bb0245","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1111\/bph.15178","article-title":"ARRIVE 2.0 and the British Journal of pharmacology: updated guidance for 2020","volume":"177","author":"Lilley","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2024.122792_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9020386","article-title":"Characteristics and Dysbiosis of the gut microbiome in renal transplant recipients","volume":"9","author":"Swarte","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.lfs.2024.122792_bb0255","doi-asserted-by":"crossref","first-page":"eabn7566","DOI":"10.1126\/scitranslmed.abn7566","article-title":"Gut microbiome dysbiosis is associated with increased mortality after solid organ transplantation","volume":"14","author":"Swarte","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lfs.2024.122792_bb0260","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2119\/molmed.2015.00126","article-title":"Differential sensitivities of fast- and slow-cycling Cancer cells to inosine monophosphate dehydrogenase 2 inhibition by mycophenolic acid","volume":"21","author":"Chen","year":"2015","journal-title":"Mol. Med."},{"key":"10.1016\/j.lfs.2024.122792_bb0265","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1096\/fj.201601002","article-title":"Cell proliferation within small intestinal crypts is the principal driving force for cell migration on villi","volume":"31","author":"Parker","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2024.122792_bb0270","doi-asserted-by":"crossref","first-page":"1153188","DOI":"10.3389\/fmicb.2023.1153188","article-title":"Probiotics treatment ameliorated mycophenolic acid-induced colitis by enhancing intestinal barrier function and improving intestinal microbiota dysbiosis in mice","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.lfs.2024.122792_bb0275","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40360-021-00536-4","article-title":"Alteration of the gut microbiome in mycophenolate-induced enteropathy: impacts on the profile of short-chain fatty acids in a mouse model","volume":"22","author":"Jardou","year":"2021","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.lfs.2024.122792_bb0280","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1007\/s10620-012-2259-4","article-title":"Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription","volume":"57","author":"Wang","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.lfs.2024.122792_bb0285","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/gut.52.10.1442","article-title":"Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E1 and E2 production by intestinal myofibroblasts","volume":"52","author":"Willemsen","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2024.122792_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.715611","article-title":"Role of barrier integrity and dysfunctions in maintaining the healthy gut and their health outcomes","volume":"12","author":"Panwar","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.lfs.2024.122792_bb0295","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/00007691-200412000-00004","article-title":"Characterization of a phase 1 metabolite of mycophenolic acid produced by CYP3A4\/5","volume":"26","author":"Picard","year":"2004","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.lfs.2024.122792_bb0300","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/2472555217725264","article-title":"Amoxapine demonstrates incomplete inhibition of \u03b2-Glucuronidase activity from human gut microbiota","volume":"23","author":"Yang","year":"2018","journal-title":"SLAS Discov"},{"key":"10.1016\/j.lfs.2024.122792_bb0305","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.str.2017.05.003","article-title":"An atlas of \u03b2-Glucuronidases in the human intestinal microbiome","volume":"25","author":"Pollet","year":"2017","journal-title":"Structure"},{"key":"10.1016\/j.lfs.2024.122792_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.826994","article-title":"\u03b2-Glucuronidase pattern predicted from gut metagenomes indicates potentially diversified Pharmacomicrobiomics","volume":"13","author":"Candeliere","year":"2022","journal-title":"Front. Microbiol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524003825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524003825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T10:59:53Z","timestamp":1725879593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524003825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":62,"alternative-id":["S0024320524003825"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122792","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiota biotransformation of drug glucuronides leading to gastrointestinal toxicity: Therapeutic potential of bacterial \u03b2-glucuronidase inhibition in mycophenolate-induced enteropathy","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"122792"}}